Inhibrx Biosciences Down Over 26%, On Track for Record Percent Decrease -- Data Talk
Dow Jones2026/10/28 18:13Inhibrx Biosciences, Inc. (INBX) is currently at $70.61, down $25.05 or 26.19%
--Would be lowest close since April 8, 2026, when it closed at $67.13
--Would be largest percent decrease on record (Based on available data back to May 28, 2024)
--Currently down four of the past five days
--Down 29.45% month-to-date; on pace for worst month on record (Based on available data back to May 28, 2024)
--Down 10.62% year-to-date; on pace for worst year on record (Based on available data back to May 28, 2024)
--Down 50.22% from its all-time closing high of $141.84 on May 6, 2026
--Down 8.36% from 52 weeks ago (Oct. 29, 2025), when it closed at $77.05
--Down 50.22% from its 52-week closing high of $141.84 on May 6, 2026
--Up 20.93% from its 52-week closing low of $58.39 on March 27, 2026
--Traded as low as $69.27; lowest intraday level since April 9, 2026, when it hit $66.41
--Down 27.59% at today's intraday low; largest intraday percent decrease on record (Based on available data back to May 28, 2024)
All data as of 2:11:31 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 28, 2026 14:13 ET (18:13 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.